Production (Stage)
Evolent Health, Inc.
EVH
$7.21
-$0.15-2.04%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -24.39% | 16.27% | 21.60% | 37.94% | 49.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -24.39% | 16.27% | 21.60% | 37.94% | 49.56% |
| Cost of Revenue | -28.82% | 25.62% | 39.87% | 53.52% | 72.49% |
| Gross Profit | -1.57% | -25.50% | -35.15% | -8.84% | -11.18% |
| SG&A Expenses | 11.54% | 4.93% | -22.71% | -24.97% | -11.17% |
| Depreciation & Amortization | -18.46% | -1.03% | -8.34% | -7.05% | 0.78% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.96% | 22.37% | 26.04% | 34.52% | 51.93% |
| Operating Income | -70.76% | -102.15% | -405.53% | 292.04% | -44.57% |
| Income Before Tax | -277.79% | 50.23% | 23.05% | 103.85% | 81.04% |
| Income Tax Expenses | 160.18% | 92.35% | 88.85% | 75.46% | 100.83% |
| Earnings from Continuing Operations | -273.95% | 31.75% | 8.64% | 104.65% | 13.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -273.95% | 31.75% | 8.64% | 104.65% | 13.52% |
| EBIT | -70.76% | -102.15% | -405.53% | 292.04% | -44.57% |
| EBITDA | -32.96% | 31.65% | -76.39% | 59.87% | -12.26% |
| EPS Basic | -183.48% | 26.98% | 8.02% | 85.03% | 9.28% |
| Normalized Basic EPS | -2,449.28% | -127.11% | -200.23% | 115.76% | 103.54% |
| EPS Diluted | -183.48% | 26.98% | 8.02% | 85.03% | 9.28% |
| Normalized Diluted EPS | -2,449.28% | -127.11% | -200.23% | 115.76% | 103.54% |
| Average Basic Shares Outstanding | 1.03% | 1.27% | 2.30% | 3.06% | 5.90% |
| Average Diluted Shares Outstanding | 1.03% | 1.27% | 2.30% | 3.06% | 5.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.76% | -0.36% | -0.10% | 23.31% | -0.61% |